Pharmacodynamics Flashcards

(55 cards)

1
Q

Pharmacodynamics

A

The study of the physiological and biochemical interactions of drug molecules with their target tissues and receptors responsible for their ultimate drug effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Ligand

A

any molecule that binds to a receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Drug

A

exogenous ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Neurotransmitters, hormones, peptides

A

endogenous ligands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Receptor

A

protein molecule on cell surface or within the cell that is the initial site of action of a biological agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

receptor examples

A

neurotransmitters, hormones, peptides, drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Extracellular receptors

A

are localized to the cell surface and bind water-soluble ligands (e.g. neurotransmitters)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

intracellular receptors

A

bind lipid-soluble ligands within the cell (e.g. steroid hormone receptors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

extracellular receptor types are common targets for

A

psychoactive drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ligand-gated ion channels

A

Postsynaptic neurotransmitter receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

G-protein coupled receptors (GPCR)

A

Metabotropic receptors
Intracellular second messenger

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Receptor kinases

A

Common for cytokine, peptide hormone receptors (e.g. Insulin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

intracellular receptor types are common targets for

A

steroid hormones and lipophilic compounds (and some drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

intracellular chemicals

A

Glucocorticoids (stress hormones)
Androgen/estrogens (sex hormones)
Endocannabinoids (intracellular GPCR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Intracellular receptors are located

A

in cytoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hormone receptors

A

Translocate to nucleus on hormone binding
Function as transcription factors
Directly induce changes in gene expression by binding to specific response element

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Agonist

A

interactions are those that elicit a biological effect on the receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Antagonist

A

interactions are those preventing or blocking a biological effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

dose-response

A

With increasing concentration of agonist, the biological response is greater.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Potency

A

ED50 is the dose required to elicit a half-maximal effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

TD50

A

is a measure of the potency of a drug at eliciting a toxic response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

LD50

A

measures the potency at eliciting a lethal effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Therapeutic index

A

reflects the margin of safety between drug efficacy and adverse effects

24
Q

therapeutic index calculation

A

TI = TD50 / ED50

25
In contrast to agonists, antagonists can be
be reversible or irreversible
26
Reversible antagonists can be displaced by the
endogenous agonist
27
Competitive antagonism
Reduces agonist potency but not efficacy
28
Non-competitive antagonists cannot be
displaced by agonists
29
Irreversible antagonists
Binds irreversibly to the same binding site as an endogenous ligand
30
Non-competitive antagonists Reduce drug
efficacy and sometimes potency
31
Allosteric modulators
Binds to a different site on the receptor than the endogenous ligand
32
Allosteric modulators Affects receptor
function through other conformational effects on the protein
33
Partial agonists
Binds same site as endogenous ligand but elicit a less than maximal response
34
Partial agonists Can
decrease efficacy of the endogenous agonist
35
Inverse agonists
Binds receptor with constitutive activity Has opposite effect to full agonist
36
Tolerance
Diminished effect of a given dose of drug over time
37
Cross-tolerance
can cause drug interactions
38
Sensitization
Enhancement of a particular drug effect on repeated exposure
39
Cross-sensitization
occurs between drugs acting on the same receptor (e.g. cocaine and amphetamines)
40
Metabolic tolerance
Increased metabolism through enzyme induction Decreased bioavailability of drug
41
Pharmacodynamic tolerance
Changes in nerve cell function in response to drug Receptor down-regulation results in saturation and diminished effect
42
Behavioral tolerance
Context-specific tolerance
43
Habituation
First administration causes greater alteration of normal behaviour
44
Conditioning
Environment or paraphernalia act as a conditioned stimulus to initiate response
45
Persistence of tolerance influenced heavily by
metabolic and pharmacodynamic mechanisms
46
Drug dependence results from
tolerance mechanisms and is considered a key component contributing to drug addictions
47
Dependence is the
requirement for drug use in order to maintain ‘normal function’ after the development of drug tolerance
48
Tolerance to opiates is proposed to develop as a result of
compensatory mechanisms to restore homeostasis
49
Dependence =
withrawals
50
Classifications (DSM, ICD) use
dependence as the key descriptor of addictions
51
Addiction may be better defined as
compulsive drug-seeking behaviour
52
substance/behavioural addictions as
impulse control disorders
53
Intoxication
Clinically significant problematic behavioural and psychological changes associated with substance intake
54
Withdrawal
Substance-specific problematic behavioural change resulting from discontinuation of use
55
Gateway Hypothesis
he use of a drug of a lower stage is necessary but not sufficient for progression to a higher stage